Viking Global Equities II LP SEC Filings

Filed On	Filing
02 Oct 2026	D/A
03 Oct 2025	D/A
04 Oct 2024	D/A
18 Jun 2024	Form 4: Viking Global Investors Lp, 10% owner and 6 others · APi Group Corporation Sold 1,951,782 shares ($74.5M)
07 Mar 2024	Form 4: Viking Global Investors Lp, 10% owner and 6 others · APi Group Corporation Sold 3,038,617 shares ($104M)
01 Mar 2024	Form 4: Viking Global Investors Lp, 10% owner and 6 others · APi Group Corporation Received 8,200,878 shares by conversion ($202M) · Disposed of 4,065,039 shares (Other Transaction) ($150M)
04 Jan 2024	Form 4: Viking Global Investors Lp, 10% owner and 6 others · APi Group Corporation Sold 6,500,000 shares ($203M)
06 Oct 2023	D/A
26 Jun 2023	Form 4: Viking Global Performance Llc, 10% owner and 7 others · Roivant Sciences Ltd Sold 13,000,000 shares ($129M)
03 Mar 2023	D/A
12 Jul 2022	6B ORDR
14 Jun 2022	6B NTC
03 Jun 2022	40-6B/A
04 Mar 2022	D/A
28 Jan 2022	40-6B
05 Jan 2022	Form 4: Viking Global Investors Lp, 10% owner and 6 others · APi Group Corporation Acquired 200,000 5.5% Series B Perpetual Convertible Preferred Stock (Open Market Purchase) ($200M)
01 Oct 2021	Form 3: Viking Global Performance Llc, 10% owner and 7 others · Roivant Sciences Ltd Holds 751,766 shares of Common Shares
05 Mar 2021	D/A
16 Dec 2020	Form 4: Viking Global Investors Lp, 10% owner and 8 others · Adaptive Biotechnologies Corporation Sold 1,000,000 shares ($55.7M)
13 Nov 2020	Form 4: Viking Global Performance Llc, 10% owner and 7 others · Adaptive Biotechnologies Corporation Sold 2,500,000 shares ($124M)

Comments